Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.
์ข
๋ชฉ ์ฝ๋ KMDA
ํ์ฌ ์ด๋ฆKamada Ltd
์์ฅ์ผAug 01, 2005
CEOLondon (Amir)
์ง์ ์374
์ ํOrdinary Share
ํ๊ณ ์ฐ๋ ์ข
๋ฃAug 01
์ฃผ์2 Holtzman St., Science Park
๋์REHOVOT
์ฆ๊ถ ๊ฑฐ๋์NASDAQ OMX - NASDAQ BASIC
๊ตญ๊ฐIsrael
์ฐํธ ๋ฒํธ7670402
์ ํ97289406472
์น์ฌ์ดํธhttps://www.kamada.com/
์ข
๋ชฉ ์ฝ๋ KMDA
์์ฅ์ผAug 01, 2005
CEOLondon (Amir)
์ง๋ 5๋
๋์ ์ด
0.00
USD์ ๋ฐฐ๋น๊ธ์ด ๋ถ๋ฐฐ๋์์ต๋๋ค.

๋ฐ์ดํฐ ์์